CDK 4/6 inhibitors for the treatment of meningioma

Meningiomas are the most common non-metastatic brain tumors, and although the majority are relatively slow-growing and histologically benign, a subset of meningiomas are aggressive and remain challenging to treat. Despite a standard of care that includes surgical resection and radiotherapy, and rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Jacob S., Kidwell, Reilly L., Zheng, Allison, Haddad, Alex F., Aghi, Manish K., Raleigh, David R., Schulte, Jessica D., Butowski, Nicholas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354681/
https://www.ncbi.nlm.nih.gov/pubmed/35936751
http://dx.doi.org/10.3389/fonc.2022.931371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354681/
https://www.ncbi.nlm.nih.gov/pubmed/35936751
http://dx.doi.org/10.3389/fonc.2022.931371

Ejemplares similares